NCT04283981

Brief Summary

The purpose of this trial is to compare operating room time between conventional treatment techniques \[without Virtual surgical Planning (VSP)\] versus treatment with use of Virtual surgical Planning (VSP) in patients that undergo mandibular reconstruction via open reduction internal fixation (ORIF).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 25, 2020

Completed
11 months until next milestone

Study Start

First participant enrolled

January 24, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2022

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

June 20, 2024

Completed
Last Updated

June 20, 2024

Status Verified

May 1, 2024

Enrollment Period

1.8 years

First QC Date

February 19, 2020

Results QC Date

May 28, 2024

Last Update Submit

May 28, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Time Taken to Complete an Open Reduction Internal Fixation (ORIF)

    The time taken to complete an Open Reduction Internal Fixation (ORIF) \[referred to as the "plating time"\] was defined as beginning after dissection was complete and fractures were initially reduced, and ending after all fracture sites were fixated with the final screw placed.

    from start of ORIF to end of ORIF (about 2-3 hours)

Secondary Outcomes (15)

  • Number of Participants With Malocclusion

    1 week after ORIF

  • Number of Participants With Malocclusion

    3 weeks after ORIF

  • Number of Participants With Malocclusion

    6 weeks after ORIF

  • Number of Participants With Fractures That Are Not Well Aligned

    1 week after ORIF

  • Number of Participants With Fractures That Are Not Well Aligned

    3 weeks after ORIF

  • +10 more secondary outcomes

Study Arms (2)

Control Group

ACTIVE COMPARATOR
Device: Control group without use of VSP

Treatment Group

EXPERIMENTAL
Device: Treatment Group with use of VSP

Interventions

The control group will include patients that undergo mandibular reconstruction via open reduction internal fixation (intraoral or extraoral approach) in standard fashion (without virtual surgical planning assistance and occlusal splint)

Control Group

The treatment group corresponds to patients undergoing mandibular reconstruction via open reduction internal fixation (intraoral or extraoral approach) utilizing virtual surgical planning via 3D Systems, bite registration and fabrication of occlusal splint via intraoral digital scanner, and mandibular hardware

Treatment Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient consent
  • Complex mandible fracture (at least two fractures) that require ORIF of at least one fracture. This will exclude condylar fractures

You may not qualify if:

  • Patient refusal to participate in study
  • Infected mandible fracture
  • Closed reduction treatment of mandible fracture
  • Fractures older than 2-3 weeks at the time of treatment
  • Other concomitant mid-facial bone fractures (ie, zygomaticomaxillary complex (ZMC), Lefort fractures)
  • Other etiologies than trauma of the mandibular fracture or pathologic fracture secondary to benign or malignant pathology that may require resection
  • Pregnant patients will NOT be excluded from the study
  • Co-morbidities (auto-immune disease, osteoporosis, titanium or metal allergy, uncontrolled diabetes (A1c greater than 8)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Mandibular Fractures

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Jaw FracturesMaxillofacial InjuriesFacial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesSkull FracturesFractures, BoneWounds and Injuries

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Results Point of Contact

Title
Simon Young
Organization
The University of Texas Health Science Center at Houston

Study Officials

  • Timothy Woernley, DDS

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 19, 2020

First Posted

February 25, 2020

Study Start

January 24, 2021

Primary Completion

October 31, 2022

Study Completion

November 10, 2022

Last Updated

June 20, 2024

Results First Posted

June 20, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations